Skip to main content
Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.768
-0.019 (-2.38%)
At close: Mar 6, 2026, 4:00 PM EST
0.758
-0.009 (-1.22%)
After-hours: Mar 6, 2026, 4:00 PM EST

Evogene Revenue

Evogene had revenue of $314.00K in the quarter ending December 31, 2025, a decrease of -80.51%. This brings the company's revenue in the last twelve months to $8.02M, up 7.19% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.

Revenue (ttm)
$8.02M
Revenue Growth
+7.19%
P/S Ratio
0.87
Revenue / Employee
$68,513
Employees
117
Market Cap
6.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.51M2.87M50.90%
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Moolec Science 7.83M
XTL Biopharmaceuticals 968.00K
Addex Therapeutics 198.82K
Kiora Pharmaceuticals 20.00K
Alaunos Therapeutics 6.00K
Pulmatrix 3.00K
Revenue Rankings

EVGN News

More News